Moloney Securities Asset Management LLC Acquires Shares of 18,800 Astrana Health, Inc. (NASDAQ:ASTH)

Moloney Securities Asset Management LLC acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 18,800 shares of the company’s stock, valued at approximately $1,089,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. QRG Capital Management Inc. bought a new position in shares of Astrana Health in the third quarter worth $355,000. F M Investments LLC bought a new position in shares of Astrana Health in the third quarter worth $11,738,000. SteelPeak Wealth LLC bought a new position in shares of Astrana Health in the third quarter worth $39,398,000. New York State Teachers Retirement System bought a new position in shares of Astrana Health in the third quarter worth $2,515,000. Finally, Nisa Investment Advisors LLC bought a new position in shares of Astrana Health in the third quarter worth $35,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Price Performance

NASDAQ:ASTH opened at $56.00 on Wednesday. The stock has a fifty day moving average of $55.07 and a 200 day moving average of $47.23. Astrana Health, Inc. has a 52-week low of $28.86 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.84 and a current ratio of 1.84. The firm has a market capitalization of $2.75 billion, a price-to-earnings ratio of 38.89, a P/E/G ratio of 2.08 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The business had revenue of $486.30 million for the quarter, compared to the consensus estimate of $440.68 million. During the same quarter last year, the business posted $0.28 earnings per share. The company’s revenue for the quarter was up 39.7% on a year-over-year basis. On average, research analysts expect that Astrana Health, Inc. will post 1.31 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ASTH. TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. BTIG Research lifted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Robert W. Baird lifted their price objective on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Finally, Stifel Nicolaus lifted their price objective on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Astrana Health currently has an average rating of “Buy” and a consensus price target of $62.00.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.